Abstract Details

Title Rizatriptan Versus Rizatriptan Plus Rofecoxib Versus Rizatriptan Plus Tolfenamic Acid in the Acute Treatment of Migraine

Topic

Presentation(s)

Poster/Presentation
Number 154

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Muhammad Al-Lozi, MD (Washington University in Saint Louis)	Dr. Al-Lozi has nothing to disclose.
Anand Venkatraman, MBBS (Ocala Regional Medical Center)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��